Sclerodermatous graft versus host disease treated with acetretin

被引：0
|
作者：
Jarrett, P. [1 ]
Chan, W. C. [1 ]
Raj, G. [1 ]
机构：
[1] Middlemore Hosp, Dept Dermatol, Auckland 6, New Zealand
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [21] Characterization of orofacial features in sclerodermatous chronic graft-versus-host disease
    Bajonaid, Amal
    Guntaka, Praveen Kumar
    Harper, Matthew
    Cutler, Corey
    Duncan, Christine
    Villa, Alessandro
    Sroussi, Herve Y.
    Woo, Sook-Bin
    Treister, Nathaniel S.
    ORAL DISEASES, 2024, 30 (08) : 5082 - 5090
  • [22] Sclerodermatous chronic graft-versus-host disease: a report of four cases
    Tolland, JP
    Jones, FCG
    Bingham, EA
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 : 41 - 42
  • [23] Arsenic Trioxide Prevents Murine Sclerodermatous Graft-versus-Host Disease
    Kavian, Niloufar
    Marut, Wioleta
    Servettaz, Amelie
    Laude, Helene
    Nicco, Carole
    Chereau, Christiane
    Weill, Bernard
    Batteux, Frederic
    JOURNAL OF IMMUNOLOGY, 2012, 188 (10): : 5142 - 5149
  • [24] Imatinib mesylate in the treatment of sclerodermatous chronic graft-versus-host disease
    Yakoub-Agha, I.
    Magro, L.
    Catteau, B.
    Coiteux, V.
    Terriou, L.
    Jouet, J. P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S190 - S190
  • [25] Pulp Obliteration in a Patient with Sclerodermatous Chronic Graft-versus-Host Disease
    Ferreira Gomes, Camilla Borges
    Treisten, Nathaniel Simon
    Millen, Brian
    Armand, Philippe
    Friedland, Bernard
    JOURNAL OF ENDODONTICS, 2016, 42 (04) : 678 - 680
  • [26] Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
    Belle, Ludovic
    Binsfeld, Marilene
    Dubois, Sophie
    Hannon, Muriel
    Caers, Jo
    Briquet, Alexandra
    Menten, Catherine
    Beguin, Yves
    Humblet, Stephanie
    Baron, Frederic
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S317 - S318
  • [27] A Case of Sclerodermatous Graft-versus-Host Disease Responsive to Imatinib Therapy
    Lazar, Jozef
    Poonawalla, Tasneem
    Teng, Joyce M. C.
    PEDIATRIC DERMATOLOGY, 2011, 28 (02) : 172 - 175
  • [28] Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges
    White, J. M. L.
    Creamer, D.
    du Vivier, A. W. P.
    Pagliuca, A.
    Ho, A. Y.
    Devereux, S.
    Salisbury, J. R.
    Mufti, G. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (05) : 1032 - 1038
  • [29] SCLERODERMATOUS CHRONIC GRAFT-VERSUS-HOST DISEASE - ANALYSIS OF 7 CASES
    CHOSIDOW, O
    BAGOT, M
    VERNANT, JP
    ROUJEAU, JC
    CORDONNIER, C
    KUENTZ, M
    WECHSLER, J
    ANDRE, C
    TOURAINE, R
    REVUZ, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (01) : 49 - 55
  • [30] Hedgehog Signaling in Murine Chronic Sclerodermatous Graft-Versus-Host Disease
    Zerr, Pawel
    Palumbo-Zerr, Katrin
    Distler, Alfiya
    Tomcik, Michal
    Vollath, Stefan
    Munoz, Louis E.
    Beyer, Christian
    Dees, Clara
    Egberts, Friederike
    Tinazzi, Ilaria
    Del Galdo, Francesco
    Distler, Oliver
    Schett, Georg
    Spriewald, Bernd M.
    Distler, Joerg H. W.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S644 - S644
12345